792 followers
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells https://t.co/2UhSbE66HO
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells https://t.co/2UhSbE66HO
RT @filimasini: EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells https://t.co/2UhSbE66HO
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells https://t.co/2UhSbE66HO
Scientists suggest that EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type #LungCancer cells. 📑 @BMC_series 📌 https://t.co/YK0NQ2M8ew https://t.co/5LsQf22qJ3